Latest Sales Performance News

Super Retail Group reports a subdued second half in FY26 with 0.4% like-for-like sales growth, impacted by geopolitical tensions and inflation, while costs rise to $66 million due to accelerated projects.

JB Hi-Fi posted modest sales growth in Australia and The Good Guys during Q3 FY26, while New Zealand sales declined amid rising supplier costs and stock shortages heading into a critical trading period.

Mirvac Group reported robust operational results in 3Q26, driven by a 28% jump in residential sales, high occupancy across its investment portfolio, and a successful $630 million capital raise for its wholesale office fund. The company reaffirmed its FY26 guidance amid cautious risk management.

BPH Global has secured a key coastal site in South Sulawesi to boost its seaweed cultivation and processing capabilities, underpinning its vertical integration strategy across food and bio stimulant markets.

Freehill Mining’s aggregate materials sales surged in March, with quarterly sales up 60%, while the company prioritises mine planning and permitting for its Blanco y Negro copper-gold project.

Ryman Healthcare’s FY26 retirement living sales hit 1,410 ORAs, aligning with guidance despite a Q4 dip in new sales. The company reports robust aged care occupancy and expects free cash flow near NZD 180 million.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.

Xenitra Limited has secured a $30 million AUD sales agreement for Danone products with Rockcheck Group and established its Australian subsidiary as an authorised supplier, marking a major step in its China market strategy.

RLF AgTech reported a 5% increase in revenue to $14.3 million for the half-year ending December 2025, while posting a $4.08 million loss reflecting a deliberate investment phase. The company also appointed Stuart Upton as CEO to lead its next growth chapter.

SomnoMed Limited has reported a return to profitability for the half-year ending December 2025, posting a $792,000 net profit after tax on the back of a 13% revenue increase. Despite the positive turnaround, the company has elected not to pay an interim dividend.

Summerset Group Holdings delivered a record underlying profit of NZ$234.2 million in FY25, driven by strong sales and portfolio growth, while advancing its Australian village developments. Despite a dip in IFRS net profit due to portfolio revaluations, the company maintains a positive outlook with high resident satisfaction and sustainability milestones.